Sopharma AD (BUL:SFA)

Market Cap	967.94M
Revenue (ttm)	2.15B
Net Income (ttm)	77.85M
Shares Out	165.74M
EPS (ttm)	0.47
PE Ratio	12.43
Forward PE	n/a
Dividend	0.15 (2.57%)
Ex-Dividend Date	Nov 7, 2024

Volume	235
Average Volume	6,254
Open	5.80
Previous Close	5.80
Day's Range	5.72 - 5.80
52-Week Range	5.56 - 6.68
Beta	-0.02
RSI	56.36
Earnings Date	Apr 30, 2025

About Sopharma AD

Sopharma AD produces, distributes, and exports pharmaceutical products in Europe, Bulgaria, and internationally. The company operates through Production of Pharmaceutical Products; Distribution of Pharmaceutical Products (Goods); and Others. It offers Carsil to treat liver disease; Tempalgin and Analgin, a painkiller; Tabex, drug used for smoking secession; Tribestan, drug used for stimulation of the male reproductive system; Broncholytin, which is used to suppress cough; Nivalin, used for diseases of the peripheral nervous system; Methylpredni...

• Industry: Pharmaceutical Preparations
• Founded: 1933
• Employees: 4,721
• Stock Exchange: Bulgarian Stock Exchange
• Ticker Symbol: SFA

Financial Performance

In 2024, Sopharma AD's revenue was 2.15 billion, an increase of 13.62% compared to the previous year's 1.89 billion. Earnings were 77.85 million, a decrease of -18.24%.